Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients (NEIHR)
Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients:A Multicentre Randomized Double-Blind Trail of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease
Sponsor: First Affiliated Hospital, Sun Yat-Sen University
Terminated
There were few eligible subjects from other centers.
Other terminated trials from First Affiliated Hospital, Sun Yat-Sen University
See all terminations from First Affiliated Hospital, Sun Yat-Sen University
Other Chronic Renal Disease trials with similar outcome
A PHASE4 clinical study on Chronic Renal Disease, this trial is terminated or withdrawn. The trial is conducted by First Affiliated Hospital, Sun Yat-Sen University and has accumulated 7 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jul 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2023 [monthly]
Terminated PHASE4
-
Dec 2019 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 2 earlier versions
-
Jun 2018 — Dec 2019 [monthly]
Terminated PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE4
First recorded
Nov 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- First Affiliated Hospital, Sun Yat-Sen University
- Guangdong Provincial People's Hospital
- Guangzhou General Hospital of Guangzhou Military Command
- Nanfang Hospital, Southern Medical University
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
For direct contact, visit the study record on ClinicalTrials.gov .